Making sense of ‘side effects’
Counterpublic health in the era of direct-acting antivirals
Bibliographic Data
| ID | 14909545 |
|---|---|
| Authors | J Bryant (0000-0002-5271-2881, UNSW Sydney, corresponding author), Jake Rance (0000-0001-7782-1235, UNSW Sydney), Peter Hull (0000-0002-3896-9373, UNSW Sydney), Limin Mao (0000-0003-0995-5789, UNSW Sydney), Carla Treloar (0000-0002-8230-0386, UNSW Sydney) |
| Year | 2019 |
| Volume | 72 |
| Pages | 77-83 |
| Publication date | 2019-10-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Drug Policy (JOURNAL) |
| Journal identifiers | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Publisher | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2019.06.002 |
| PMID | 31221475 |
| OpenAlex | W2949251265 |
| Language | EN |
| Citations received | 20 |
| References cited | 37 |
Distrust · Normative · Political science · Psychological intervention · Public health · Public relations · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · HIV/AIDS Research and Interventions · Law · Medicine · Nursing
People engaged in opioid agonist treatment as a counterpublic during the Covid ‐19 pandemic in Australia
Client resistance to hepatitis C treatment initiation in opioid agonist treatment clinics in Sydney, Australia
The ‘missing’ in the ‘endgame’ of hepatitis C elimination
Countering 'the moral science of biopolitics
Hepatitis C cure as a 'gathering
Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs)
How to have sex in a pandemic
Logics of control and self-management in narratives of people living with HIV, hepatitis C and hepatitis B
Peer to peer communication about hepatitis C treatment amongst people who inject drugs
Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries
Structural competency in the post-prison period for people who inject drugs
Not just one box that you tick off’ – Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective
Factors associated with hepatitis C testing, treatment, and current hepatitis C infection among men and women who inject drugs
Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up
Elimination of hepatitis C virus infection among people who use drugs
It's time!”
Individual and network factors associated with HCV treatment uptake among people who inject drugs
Exhausted practical sovereignty and lateral agency
Priorities and practices of risk reduction among gay and bisexual men in Australia who use crystal methamphetamine for sex
Post-crisis imaginaries in the time of direct-acting antiviral hepatitis C treatment
Measuring stigma in people with HIV
Pleasure consuming medicine
Beyond the willing & the waiting’ — The role of peer-based approaches in hepatitis C diagnosis & treatment
Caring and curing
The impact of harm reduction programs and police interventions on the number of syringes collected from public spaces. A time series analysis in Barcelona, 2004–2014
Initial outcomes of integrated community-based hepatitis C treatment for people who inject drugs
Delivering direct acting antiviral therapy for hepatitis C to highly marginalised and current drug injecting populations in a targeted primary health care setting
Prejudice among health care workers toward injecting drug users with hepatitis C
Managing expense and expectation in a treatment revolution
Time to invest in a ‘counterpublic health’ approach
Building inclusion, maintaining marginality
Publics and counterpublics (abbreviated version)
Anthropology and epidemiology on drugs
At risk of what? Possibilities over probabilities in the study of young lives
Incorporating Pharmakon
The politics of place(ment)
Methadone as Social Control
Counterpublic health and the design of drug services for methamphetamine consumers in Melbourne
Science and scepticism
Rethinking the Public Sphere
| Unique citing works | 20 |
|---|---|
| Citations per year | 2,86 |
| Citation span | 2019 - 2024 (6) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 20 |